Making SENSE-Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry

BMC Neurology

Volumn 15, Issue 1, 2015, Pages

  Kellinghaus, Christoph ^a   Lang, Nicolas ^b   Rossetti, Andrea O ^c   Rüegg, Stephan ^d   Tilz, Christian ^e   Trinka, Eugen ^f,j   Unterberger, Iris ^g   Uzelac, Zeljko ^h   Rosenow, Felix ⁱ  

^a Andreas Bannowsky Ltd   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e KRANKENHAUS BARMHERZIGE BRÜDER REGENSBURG   (Germany)

^f Christian Doppler Klinik   (Austria)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h UNIVERSITY HOSPITAL ULM   (Germany)

ⁱ PHILIPPS UNIVERSITY MARBURG   (Germany)

^j UNIVERSITY OF SALZBURG   (Austria)

more..

Author keywords

AED; Anticonvulsant; Outcome; Status epilepticus

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; EPILEPTIC STATE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; TREATMENT PLANNING; ADULT; AGED; CLINICAL TRIAL; FEMALE; MALE; MIDDLE AGED; REGISTER; STATUS EPILEPTICUS;

ANTICONVULSIVE AGENT; DIAZEPAM; LORAZEPAM; MIDAZOLAM; PHENYTOIN;

ADULT; AGED; ANTICONVULSANTS; DIAZEPAM; FEMALE; HUMANS; LORAZEPAM; MALE; MIDAZOLAM; MIDDLE AGED; PHENYTOIN; PROSPECTIVE STUDIES; REGISTRIES; STATUS EPILEPTICUS;

EID: 84946723558     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-015-0486-y     Document Type: Article

References (30)

1. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22:489-501.
2. Bösebeck F, Moddel G, Anneken K, Fischera M, Evers S, Ringelstein EB, et al. [Refractory status epilepticus: diagnosis, therapy, course, and prognosis]. Nervenarzt. 2006;77:1159-64. 1166.
3. Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia. 2006;47:1499-503.
4. Theodore WH, Porter RJ, Albert P, Kelley K, Bromfield E, Devinsky O, et al. The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology. 1994;44:1403-7.
5. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27-34.
6. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792-8.
7. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345:631-7.
8. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366:591-600.
9. Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515-23.
10. Rona S, Rosenow F, Arnold S, Carreno M, Diehl B, Ebner A, et al. A semiological classification of status epilepticus. Epileptic Disord. 2005;7:5-12.
11. Shorvon S, Baulac M, Cross H, Trinka E, Walker M. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia. 2008;49:1277-85.
12. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802-18.
13. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA. 1983;249:1452-4.
14. Gilad R, Izkovitz N, Dabby R, Rapoport A, Sadeh M, Weller B, et al. Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand. 2008;118:296-300.
15. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology. 2006;67:340-2.
16. Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol. 2012;259:645-8.
17. Rossetti AO, Milligan TA, Vulliemoz S, Michaelides C, Bertschi M, Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care. 2011;14:4-10.
18. Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10:922-30.
19. Sánchez Fernández I, Abend NS, Agadi S, An S, Arya R, Brenton JN, et al. Time from convulsive status epilepticus onset to anticonvulsant administration in children. Neurology. 2015;84:2304-11.
20. Kämppi L, Mustonen H, Soinila S. Analysis of the delay components in the treatment of status epilepticus. Neurocrit Care. 2013;19:10-8.
21. Boske A, Cook A, Bensalem-Owen M. Assessment of time of administration from time of order of anti-epileptic drugs in status epilepticus. Neurology. 2013;80(Meeting Abstracts 1):S48. 007.
22. Bleck T, Cock H, Chamberlain J, Cloyd J, Connor J, Elm J, et al. The established status epilepticus trial 2013. Epilepsia. 2013;54 Suppl 6:89-92.
23. Cock HR. Established status epilepticus treatment trial (ESETT). Epilepsia. 2011;52 Suppl 8:50-2.
24. Beniczky S, Hirsch LJ, Kaplan PW, Pressler R, Bauer G, Aurlien H, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia. 2013;54 Suppl 6:28-9.
25. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12:316-25.
26. Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol. 2008;255:1561-6.
27. Rosenow F, Besser R, Hamer HM, Holtkamp M, Kluge S, Knake S, et al. Status epilepticus im Erwachsenenalter. In: Kommission für Leitlinien der DGN, editor. Leitlinien für Diagnostik und Therapie in der Neurologie. 5th edition. Stuttgart: Thieme; 2012. p. 48-57.
28. Agan K, Afsar N, Midi I, Us O, Aktan S, Aykut-Bingol C. Predictors of refractoriness in a Turkish status epilepticus data bank. Epilepsy Behav. 2009;14:651-4.
29. Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam. Epilepsia. 2011;52:1292-6.
30. Kellinghaus C, Stögbauer F. Treatment of status epilepticus in a large community hospital. Epilepsy Behav. 2012;23:235-40.